Mr. Timothy E Dineen, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 Alycia Drive, Richmond, KY 40475 Phone: 859-626-1504 Fax: 859-626-3663 |
Jeniffer Lynn Huhn, DO Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 793 Eastern Byp, Suite G2, Richmond, KY 40475 Phone: 859-626-0074 Fax: 859-626-3265 |
William L. Cooper, M.D. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 103 Alycia Dr, Richmond, KY 40475 Phone: 859-626-3412 Fax: 859-626-3663 |
Benjamin Homer Mcquaide, M.D. Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 781 Eastern Byp, Richmond, KY 40475 Phone: 859-623-8827 Fax: 859-623-8810 |
Dr. John R Simmons, DO Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 793 Eastern Byp, G2, Richmond, KY 40475 Phone: 859-626-0074 Fax: 859-626-3265 |
Dr. Farah Ian Brown, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 Alycia Dr, Richmond, KY 40475 Phone: 855-672-3888 Fax: 855-672-3888 |
Sandra L. Swayze, M.D. Radiology - Radiation Oncology Medicare: Not Enrolled in Medicare Practice Location: 793 Eastern Byp, Suite G2, Richmond, KY 40475 Phone: 859-626-0074 Fax: 859-626-3265 |
News Archive
Pfizer is entering into a three-year, $9-million research collaboration with the BC Cancer Agency and the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver General Hospital (VGH) Centre of Excellence, to tackle new treatment avenues for breast, ovarian and prostate cancer. This is the single-largest investment by Pfizer into British Columbia's public research sector, and it recognizes the strength and world-class cancer expertise that resides in this province.
A brain-training task that increases the number of items an individual can remember over a short period of time may boost performance in other problem-solving tasks by enhancing communication between different brain areas.
Biothera announced today top-line results from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) that evaluated its immunotherapeutic drug candidate, Imprime PGG®, with cetuximab (Erbitux®), carboplatin and paclitaxel compared with the monoclonal antibody and chemotherapy combination alone.
Cancer survival estimates are important to patients, physicians, clinical trials planning and resource allocation. Predictions by present statistical methods tend to lag behind current outcomes.
The Obama administration and the Congressional Budget Office have indicated that Social Security beneficiaries will not receive a cost-of-living increase in 2010 or 2011, which would have "major implications for Medicare," the New York Times reports.
› Verified 2 days ago